Stock 7775 DAIKEN MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Daiken Medical Co., Ltd.

Equities

7775

JP3482500000

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
556 JPY +0.91% Intraday chart for Daiken Medical Co., Ltd. +1.09% +8.38%
01-31 Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Full Year March 31, 2024 CI
01-31 Daiken Medical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 16,017 18,875 17,496 14,652 13,818 15,973 - -
Enterprise Value (EV) 1 17,247 19,426 18,279 15,067 14,057 15,973 15,973 15,973
P/E ratio 19.1 x 22 x 25.9 x 17.6 x 19.4 x 16.2 x 14.3 x 12.7 x
Yield 3.6% 3.04% 3.28% 3.92% 4.16% 3.78% 3.96% 4.14%
Capitalization / Revenue 1.91 x 2.21 x 2.23 x 1.72 x 1.51 x 1.63 x 1.54 x 1.45 x
EV / Revenue 1.91 x 2.21 x 2.23 x 1.72 x 1.51 x 1.63 x 1.54 x 1.45 x
EV / EBITDA 10.3 x 13 x 14.9 x 10 x 10.5 x 9.02 x 7.99 x 7.1 x
EV / FCF 23,473,631 x 14,807,743 x - 15,747,415 x 17,489,251 x - 17,175,282 x 16,638,555 x
FCF Yield 0% 0% - 0% 0% - 0% 0%
Price to Book 2.77 x 3.1 x 2.83 x 2.28 x 2.1 x 2.26 x 2.08 x 1.9 x
Nbr of stocks (in thousands) 28,807 28,728 28,728 28,728 28,728 28,728 - -
Reference price 2 556.0 657.0 609.0 510.0 481.0 556.0 556.0 556.0
Announcement Date 19-05-15 20-05-15 21-05-14 22-05-13 23-05-15 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 8,406 8,523 7,862 8,540 9,137 9,800 10,350 11,000
EBITDA 1 1,552 1,448 1,178 1,465 1,321 1,770 2,000 2,250
EBIT 1 1,249 1,194 921.2 1,150 1,054 1,485 1,700 1,950
Operating Margin 14.86% 14.01% 11.72% 13.47% 11.54% 15.15% 16.43% 17.73%
Earnings before Tax (EBT) 1 1,153 1,191 944.8 1,151 1,025 1,500 1,700 1,900
Net income 1 851 859 675.2 831 712 1,035 1,175 1,325
Net margin 10.12% 10.08% 8.59% 9.73% 7.79% 10.56% 11.35% 12.05%
EPS 2 29.05 29.92 23.50 28.93 24.79 34.25 38.95 43.90
Free Cash Flow 682.3 1,275 - 930.4 790.1 - 930 960
FCF margin 8.12% 14.96% - 10.89% 8.65% - 8.99% 8.73%
FCF Conversion (EBITDA) 43.95% 88.05% - 63.5% 59.8% - 46.5% 42.67%
FCF Conversion (Net income) 80.18% 148.39% - 111.96% 110.97% - 79.15% 72.45%
Dividend per Share 2 20.00 20.00 20.00 20.00 20.00 21.00 22.00 23.00
Announcement Date 19-05-15 20-05-15 21-05-14 22-05-13 23-05-15 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2020 S2 2021 S1 2022 Q1 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 Q3
Net sales 1 4,248 4,275 3,771 1,977 4,086 2,334 2,120 4,454 2,196 2,258 4,454 2,442 2,241 4,683 2,361 2,463 4,824 2,582 2,396 4,978 2,520 2,620 2,730
EBITDA - - - - - - - - - - - - - - - - - - - - - - -
EBIT 1 565 629 452 249 565 368 217 585 288 317 605 364 85 449 339 406 745 492 264 756 390 450 540
Operating Margin 13.3% 14.71% 11.99% 12.59% 13.83% 15.77% 10.24% 13.13% 13.11% 14.04% 13.58% 14.91% 3.79% 9.59% 14.36% 16.48% 15.44% 19.05% 11.02% 15.19% 15.48% 17.18% 19.78%
Earnings before Tax (EBT) 1 579 612 488 249 564 368 219 587 288 316 604 364 57 421 341 409 750 487 258 750 390 450 540
Net income 1 414 445 350 176 400 262 169 431 202 227 429 259 24 283 244 293 537 351 162 513 280 320 380
Net margin 9.75% 10.41% 9.28% 8.9% 9.79% 11.23% 7.97% 9.68% 9.2% 10.05% 9.63% 10.61% 1.07% 6.04% 10.33% 11.9% 11.13% 13.59% 6.76% 10.31% 11.11% 12.21% 13.92%
EPS 14.42 - 12.20 6.140 13.93 9.120 - - 7.040 - 14.94 9.010 - - 8.520 - 18.72 12.20 - - - - -
Dividend per Share 9.000 - 9.000 - 9.000 - - - - - 9.000 - - - - - 9.000 - - - - - -
Announcement Date 19-10-31 20-05-15 20-10-30 21-07-30 21-10-29 22-01-31 22-05-13 22-05-13 22-07-29 22-10-31 22-10-31 23-01-31 23-05-15 23-05-15 23-07-31 23-10-31 23-10-31 24-01-31 - - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1,230 551 783 415 239 - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 0.7923 x 0.3806 x 0.6648 x 0.2832 x 0.1809 x - - -
Free Cash Flow 682 1,275 - 930 790 - 930 960
ROE (net income / shareholders' equity) 13.7% 14.5% 11% 13.2% 10.9% 15.4% 16.3% 16.9%
ROA (Net income/ Total Assets) 11.3% 11% 8.8% 10.6% 9.6% 13.4% 14.5% 15.2%
Assets 1 7,555 7,797 7,673 7,817 7,415 7,724 8,103 8,717
Book Value Per Share 2 201.0 212.0 215.0 224.0 229.0 247.0 267.0 292.0
Cash Flow per Share 39.30 38.70 32.40 39.90 34.10 - - -
Capex 1 199 162 312 203 227 300 300 450
Capex / Sales 2.36% 1.9% 3.97% 2.38% 2.48% 3.06% 2.9% 4.09%
Announcement Date 19-05-15 20-05-15 21-05-14 22-05-13 23-05-15 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Daiken Medical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
DAIKEN MEDICAL CO., LTD. Stock Daiken Medical Co., Ltd.
+8.38% 104M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.37% 12.39B
PENUMBRA, INC. Stock Penumbra, Inc.
-17.09% 8.08B
MASIMO CORPORATION Stock Masimo Corporation
+16.88% 7.25B
GETINGE AB Stock Getinge AB
+3.57% 5.86B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+11.77% 5.35B
APT MEDICAL INC. Stock APT Medical Inc.
+29.65% 4.63B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-17.74% 4.19B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-35.26% 2.44B
SKAN GROUP AG Stock SKAN Group AG
+3.09% 2.07B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 7775 Stock
  4. Financials Daiken Medical Co., Ltd.